연구동향 분석

SMARCA4/BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non–small cell lung cancer

Anurag Mehta Divya Bansal Rupal Tripathi Ankush Jajodia 2021년

논문상세정보
인용/피인용
' SMARCA4/BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non–small cell lung cancer' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • BRG1 protein
  • Non–small cell lung carcinoma
  • SMARCA4
  • adenocarcinoma
  • lung
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
199 0

0.0%

' SMARCA4/BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non–small cell lung cancer' 의 참고문헌

  • WHO classification of tumors of the lung, pleura, thymus and heart
  • The spectrum of SWI/SNF mutations, ubiquitous in human cancers
    Shain AH [2013]
  • The expanding family of SMARCB1(INI1)-deficient neoplasia : implications of phenotypic, biological, and molecular heterogeneity
    Agaimy A [2014]
  • Selective killing of SMARCA2-and SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type cells by inhibition of EZH2 : in vitro and in vivo preclinical models
  • SWI/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma
    Stewart CJ [2015]
  • SWI/SNF Complex-deficient undifferentiated/rhabdoid carcinomas of the gastrointestinal tract : a series of 13 cases highlighting mutually exclusive loss of SMARCA4 and SMARCA2 and frequent co-inactivation of SMARCB1 and SMARCA2
    Agaimy A [2016]
  • SMARCA4/BRG1-deficient non-small cell lung carcinomas : a case series and review of the literature
  • SMARCA4/BRG1 is a novel prognostic biomarker predictive of cisplatin-based chemotherapy outcomes in resected non-small cell lung cancer
    Bell EH [2016]
  • SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas
    Rekhtman N [2020]
  • SMARCA4-deficient thoracic sarcomas : clinicopathologic study of 30 cses with an emphasis on their nosology and differential diagnoses
    Perret R [2019]
  • SMARCA4-deficient thoracic sarcoma : a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior
    Sauter JL [2017]
  • SMARCA4-deficient pulmonary adenocarcinoma : clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1(neg)/CK7(pos)/Hep-Par-1(pos)immunophenotype
    Agaimy A [2017]
  • SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
    Le Loarer F [2015]
  • SMARCA4 and SMARCA2deficiency in non-small cell lung cancer : immunohistochemical survey of 316 consecutive specimens
    Herpel E [2017]
  • Recurrent SMARCA4 mutations in small cell carcinoma of the ovary
    Jelinic P [2014]
  • Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden
    Naito T [2019]
  • Molecular pathways : SWI/SNF(BAF)complexes are frequently mutated in cancer-mechanisms and potential therapeutic insights
    Wang, X. [2014]
  • Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features
    Matsubara D [2013]
  • Incidence of ROS1-rearranged non-small-cell lung carcinoma in India and efficacy of crizotinib in lung adenocarcinoma patients
    Mehta A [2020]
  • Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer
    Oike T [2013]
  • Exceptionally rapid response to pembrolizumab in a SMARCA4-deficient thoracic sarcoma overexpressing PD-L1 : a case report
    Takada K [2019]
  • Comprehensive molecular profiling of lung adenocarcinoma
  • Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities
    Yoshida A [2017]
  • Chromatin remodeling factor BRG1 regulates stemness and chemosensitivity of glioma initiating cells
    Ganguly D [2018]
  • AACR Project GENIE : powering precision medicine through an international consortium